Deficiency of Endothelial CD40 Induces a Stable Plaque Phenotype and Limits Inflammatory Cell Recruitment to Atherosclerotic Lesions in Mice.


Journal

Thrombosis and haemostasis
ISSN: 2567-689X
Titre abrégé: Thromb Haemost
Pays: Germany
ID NLM: 7608063

Informations de publication

Date de publication:
11 2021
Historique:
aheadofprint: 22 02 2021
pubmed: 23 2 2021
medline: 11 3 2022
entrez: 22 2 2021
Statut: ppublish

Résumé

The co-stimulatory CD40L-CD40 dyad exerts a critical role in atherosclerosis by modulating leukocyte accumulation into developing atherosclerotic plaques. The requirement for cell-type specific expression of both molecules, however, remains elusive. Here, we evaluate the contribution of CD40 expressed on endothelial cells (ECs) in a mouse model of atherosclerosis. Atherosclerotic plaques of apolipoprotein E-deficient ( Endothelial deficiency of CD40 in mice promotes structural features associated with a stable plaque phenotype in humans and decreases leukocyte adhesion. These results suggest that endothelial-expressed CD40 contributes to inflammatory cell migration and consecutive plaque formation in atherogenesis.

Identifiants

pubmed: 33618394
doi: 10.1055/a-1397-1858
doi:

Substances chimiques

CD40 Antigens 0
Vascular Cell Adhesion Molecule-1 0
Intercellular Adhesion Molecule-1 126547-89-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1530-1540

Subventions

Organisme : 366904753
ID : German Research Foundation
Organisme : 81X2800139
ID : German Center for Cardiovascular Research
Organisme : 853425
ID : European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program
Organisme : MOTI-VATE scholarship
ID : Forschungskomission of the University of Freiburg
Organisme : Kaltenbach scholarship
ID : Else Kröner-Fresenius-Stiftung
Organisme : Berta-Ottenstein-Program for Advanced Clinician Scientists
ID : Deutsche Herzstiftung

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

L. F., P. S., L. S. M., J. M., C. W., I. H., C. v. z. M., C. B., and D. W. are members of the Collaborative Research Centre SFB1425 of the German Research Foundation.

Auteurs

Mark Colin Gissler (MC)

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Philipp Scherrer (P)

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Nathaly Anto-Michel (N)

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Jan Pennig (J)

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Natalie Hoppe (N)

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Lisa Füner (L)

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Carmen Härdtner (C)

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Peter Stachon (P)

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Xiaowei Li (X)

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Lucia Sol Mitre (LS)

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Timoteo Marchini (T)

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Josef Madl (J)

Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Germany.

Carolin Wadle (C)

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Ingo Hilgendorf (I)

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Constantin von Zur Mühlen (C)

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Christoph Bode (C)

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Christian Weber (C)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, Munich, Germany.
German Center for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany.
Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.

Esther Lutgens (E)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, Munich, Germany.
German Center for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany.
Department of Medical Biochemistry, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

Dennis Wolf (D)

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Norbert Gerdes (N)

Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.

Andreas Zirlik (A)

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Division of Cardiology, Medical University of Graz, Graz, Austria.

Florian Willecke (F)

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Klinik für Allgemeine und Interventionelle Kardiologie/Angiologie, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Bochum, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH